McKinsey & Co to pay $550m over role in opioid crisis

McKinsey suggested ways to “turbocharge” sales of Purdue’s OxyContin painkiller at a time when the legal market for the opioid-based medicine was shrinking due to a wave of negative publicity, according to the Massachusetts Attorney General.
Read More

Leave a Comment

Your email address will not be published. Required fields are marked *